Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?
Indirect evidence for disturbed structural connectivity of subcortical fiber tracts in schizophrenia has been obtained from functional neuroimaging and electrophysiologic studies. During the past few years, new structural imaging methods have become available. Diffusion tensor imaging and magnetization transfer imaging (MTI) have been used to investigate directly whether fiber tract abnormalities are indeed present in schizophrenia. To date, findings are inconsistent that may express problems related to methodological issues and sample size. Also, pathological processes detectable with these new techniques are not yet well understood. Nevertheless, with growing evidence of disturbed structural connectivity, myelination has been in the focus of postmortem investigations. Several studies have shown a significant reduction of oligodendroglial cells and ultrastructural alterations of myelin sheats in schizophrenia. There is also growing evidence for abnormal expression of myelin-related genes in schizophrenia: Neuregulin (NRG1) is important for oligodendrocyte development and function, and altered expression of erbB3, one of the NRG1 receptors, has been shown in schizophrenia patients. This is consistent with recent genetic studies suggesting that NRG1 may contribute to the genetic risk for schizophrenia. In conclusion, there is increasing evidence from multiple sides that structural connectivity might be pathologically changed in schizophrenia illness. Up to the present, however, it has not been possible to decide whether alterations of structural connectivity are intrinsically linked to the primary risk factors for schizophrenia or to secondary downstream effects (ie, degeneration of fibers secondarily caused by cortical neuronal dysfunction)-an issue that needs to be clarified by future research.
Konrad
Andreas
A
Department of Psychiatry, Johannes Gutenberg-University, Mainz, Germany. andreas_konrad@gmx.de
Winterer
Georg
G
D038524:Diffusion Magnetic Resonance Imaging; D018815:Genes, erbB / Q000235:genetics; D006801:Humans; D008279:Magnetic Resonance Imaging; D009186:Myelin Sheath / Q000235:genetics / Q000473:pathology; D009412:Nerve Fibers / Q000473:pathology; D009415:Nerve Net / Q000473:pathology*; D009419:Nerve Tissue Proteins / Q000235:genetics; D020890:Neuregulin-1; D009836:Oligodendroglia / Q000473:pathology; D012559:Schizophrenia / Q000235:genetics / Q000473:pathology*
C094131:NRG1 protein, human; D009419:Nerve Tissue Proteins; D020890:Neuregulin-1